Clear vision after 40: Reduce your need for reading and computer glasses with Refractive Lens Exchange.
Refractive lens exchange (RLE), also called clear lens extraction, replaces the natural lens with an intraocular lens (IOL) in patients wishing to correct various refractive errors – this includes high farsightedness, high nearsightedness, or presbyopia, without undergoing a corneal modification procedure such as LASIK. RLE is also a suitable procedure for someone who is considering LASIK but is over the age of 40 as it is able to correct a range of focus including distance and near. Most patients lose their ability to focus at near in their 40’s (presbyopia) and must wear progressive or bifocal glasses or separate reading glasses. Those patients therefore benefit more from RLE with a presbyopia correcting lens implant which can reduce their need for reading glasses than they would from LASIK which can only correct for distance vision
The refractive lens exchange procedure is similar to cataract surgery; the only difference is that refractive lens exchange is performed to achieve refractive correction rather than to remove a cloudy lens (cataract). Refractive lens exchange involves a rapid recovery and offers patients dramatic improvement in vision quality.
Typically, the lens replacement surgery takes about 15 minutes, often with both eyes done at the same sitting. The procedure is done on an outpatient basis with drops used to freeze the eye so you won’t experience pain or discomfort. Because the IOL is inside of the eye, rather than on the surface like a contact lens, it’s virtually invisible to others and you will not feel it inside your eye.
After surgery, vision is blurry for a few days but patients recover quickly and are back to normal activities within 1 week. They enjoy clearer vision and greater focusing power with minimal dependence on glasses which lasts for life, This procedure also means the patient will not need cataract surgery in the future. The initial recovery period is about one week, after which you can resume normal activities. It is common to have dry or irritated eyes initially after surgery and this can take a few months to settle but artificial tears help.
Prism offers a wide range of IOLs and we will help to customize a solution that meets your needs.
You May be a Candidate for Clear Lens Extraction if You:
Want to reduce or eliminate your dependence on glasses or contacts
Are over 40 years old*
Have high myopia (nearsightedness), high hyperopia (farsightedness), or presbyopia, with or without cataracts
Have early signs and symptoms of cataracts
*Presbyopia is a naturally-occurring condition that happens to just about everyone after the age of 40. As we age, the eye’s natural lens becomes harder and thus more inflexible, causing us to lose the ability to focus close up. Presbyopia-induced loss of near vision cannot be corrected with refractive surgery such as LASIK – more commonly, patients will choose RLE with a multifocal lens to diminish their need for glasses. For those over the age of 40 with active lifestyles wishing to free themselves of the burden of glasses – this procedure is for you!
“The distance vision is spectacular I can’t even remember wearing glasses. I hardly ever wear reading glasses. The halos which were never really that bothersome just somehow went away. This is the greatest thing I’ve ever done I would pay $20,000 to do this! I feel so lucky.”
Heidi, RLE patient with Symfony EDOF lens
How Do I Get Started
You will be scheduled for testing prior to seeing the doctor. This testing helps your doctor to plan your treatment and counsel you on the various surgical treatment options so that you can choose the best fit for your eye and your needs. Refractive lens exchange surgery is an elective procedure, the advanced testing and measurements required are not covered by OHIP. Prism will provide you with information about their purpose, an itemized invoice and a consent explaining their optional nature.
After checking in at the front desk, you will be asked to complete a medical questionnaire. After this, a technician will take a medical history and perform some preliminary tests that could include visual acuity, intraocular pressure and they will often instill dilating drops (these can blur vision for several hours and it is helpful to bring a driver). Your ophthalmologist and their team of associates will examine your eyes and discuss the lens options that are right for you. After they have answered your questions about the surgery, you will then move to the surgery department where one of our surgical coordinators will review the logistics including the time and place, instructions for before and after surgery, and the drops you will need. They will also review the cataract consent documents.
Your surgery will be scheduled at TLC Oakville. You will also be scheduled for follow up visits at Prism after the surgery.
Dr. Devesh Varma, MD, FRCSC, BEng, Ophthalmologist
Glaucoma & Complex Anterior Segment Surgeon
Managing Director, Prism Eye Institute
About Dr. Varma
Dr. Varma specializes in glaucoma surgery, performing a full spectrum of complex as well as newer minimally invasive procedures. In addition to routine and refractive cataract surgery, he has particular expertise in high-risk cataracts, the repair of complications from cataract surgery and reconstruction of the front portion of the eye.
In 2010, Dr. Varma joined the Prism Eye Institute, where he is now Managing Director of the Prism Group. Prism is a large multidisciplinary eye care provider serving over 200,000 patients each year across five sites in the Greater Toronto Area. He is also Executive Vice President of Clinical Ophthalmology for Vision Group, a Canadian company that provides clinical, laser, and surgical eye care in over 65 locations across Canada and the United States.
Dr. Varma has developed collaborative care models at Prism and has himself served over 100,000 patients, performed over 15,000 surgeries, and over 30,000 laser procedures. Dr. Varma operates at Trillium Health Partners in Mississauga, Kensington Eye Institute in Toronto, and at the Prism/TLC surgery center in Oakville.
Dr. Varma is a Preceptor for Glaucoma and Advanced Segment Surgery Fellowship at the University of Toronto. He is also an Undergraduate Ophthalmology Coordinator at the Mississauga Academy of Medicine, University of Toronto. He is the founder and served four years as chairman of the Emerging Leaders Program for Ophthalmologists at the University of Toronto’s Rotman School of Management. He also co-chaired Canadian Opthalmologic Society Annual Meeting Cataract Program between 2016–2019.
Dr. Varma has special interests in angle closure glaucoma, intraocular lens technology, and minimally invasive glaucoma surgery techniques. He has published over twenty peer reviewed articles and forty scientific publications. He has delivered over 100 invited lectures.
Education
Glaucoma and Advanced Anterior Segment Surgery Fellowship, University of Toronto
Ophthalmology Residency, University of Saskatchewan
Doctor of Medicine, Dalhousie University
Bachelor of Engineering, Dalhousie University
Awards & Accomplishments
Trillium Health Partners Excellence in Teaching Award: 2014 and 2016
University of Toronto Department of Ophthalmology Fellowship Scholarship
Canadian Medical Association Young Leaders Award: 2009
Dalhousie University Medal, Engineering (#1 ranking)
Canadian Society of Mechanical Engineers Gold Medal
Memberships
Royal College of Physicians and Surgeons of Canada
College of Physicians and Surgeons of Ontario
Canadian Medical Association
Ontario Medical Association
Canadian Ophthalmological Society
Eye Physicians and Surgeons of Ontario
Canadian Glaucoma Society
American Academy of Ophthalmology
American Society of Cataract and Refractive Surgery
American Glaucoma Society
Research
Ma J, Issa M, Varma DK, Ahmed IIK. Urgent virtual eye assessments during the COVID-19 Pandemic. Clin Ophthalmol. 2022 Jun;2022(16)2069-2078.
Liu J, Ma J, Ahmed II, Varma DK. Effectiveness of a 3D-printed mask fitter in an Ophthalmology setting during COVID-19. Can J Ophthalmol. 2022 Jun;57(3)161-166.
Bala C, Poyales F, Guarro M, Mesa RR, Mearza A, Varma DK, Jasti S, Lemp-Hull J. Multicountry clinical outcomes oof a new nondiffrative presbyopia-correcting IOL. J Cataract Refract Surg. 2022 Feb 1;48(2)136-143.
Shahidi A, Lamba A, Pereira A, Smith D, Varma DK, Ahmed IK, Sheybani A. A retrospective analysis on the visual outcomes and photic phenomena following bilateral extended depth of focus intraocular lens implants. Canadian Journal of Ophthalmology. 2020 April;55(2)126-30.
Shute TS, Varma DK, Tam D, Klein T, Moinul P, Ahmed IIK, Sheybani A. Seasonal variation in the incidence of malignant glaucoma after cataract surgery. J Ophthalmic Vis Res. 2019 Jan-Mar;14(1)32-37.
Lim M, Thompson B, D’Silva C, Wang GY, Bhatnam P, Palaganas M, Reid R, Cairney J, Varma DK, Smith D and Ahmed IK. Development and reliability of an appropriateness and prioritization instrument for eye care practice: a modified Delphi process. Ophthalmic Epidemiology. October 2019.
Lamba A, Perera A, Varma DK, Shahidi A, Smith D and Ahmed IIK. Seasonal Variation in the Incidence of Malignant Glaucoma after Cataract Surgery. J Ophthalmic Vis Res. 2019 Jan-Mar;14(1):32-37.
Ahmed SF, McDermott KC, Burge WK, Ahmed IIK, Varma DK, Liao YJ, Crandal AS, Khaderi SKR. Visual function, digital behaviour and the vision performance index. Clin Ophthalmol. 2018 Dec 10;12:2553-2561.
Varma DK, Kletke SN, Rai AS and Ahmed IK. Proportion of undetected narrow angles or angle closure in cataract surgery referrals. Canadian journal of ophthalmology. 2017 Aug;52(4):366.
Varma DK, Simpson SM, Rai AS and Ahmed IK. Undetected angle closure in patients with a diagnosis of open-angle glaucoma. Canadian journal of ophthalmology. 2017 Aug;52(4):373.
Mednick ZD, Varma DK, Campos-Moeller X and Ahmed IK. Refractive predictability of a 3-piece intraocular lens platform versus its 1-piece counterpart. Canadian journal of ophthalmology. 2017 April;52(2):146.
Filek R, Hooper P, Sheidow T, Gonder J, Varma DK, Heckler L, Hodge W, Chakrabati S and Hutnik CML. Structural and functional changes to the optic nerve following panretinal photocoagulation over a 2-year time period. Eye. 2017 88:583.
Vera V, Naqi A, Belovay GW, Varma DK, and Ahmed IK. Dysphotopsia after temporal versus superior laser peripheral iridotomy: a prospective randomized paired eye trial. American journal of ophthalmology. 2014 May;157(5):929.
Varma DK, Belovay GW, Tam DY and Ahmed IK. Malignant glaucoma after cataract surgery. Journal of Cataract and Refractive Surgery. 2014 Nov:40(11):1843.
Russel KA, Milne AD, Varma DK, Josephson K, Tompson B, Lee JM. Three-dimensional morphologic nasal surface characteristics that predict the extremes of aesthetics in patients with cleft lip and palate. Cleft Palate and Craniofacial Journal. 2011 Jan;48(1):28-37.
Belovay GW, Varma DK, Ahmed IK. Cataract Surgery in Pseudoexfoliation Syndrome. Curr Opin Ophthalmol. 2010 Jan;21(1):25-34.
Haymes SA, Hutchison DM, McCormick TB, Varma DK, Nicolela MT, Leblanc RP, Chauhan BC. Glaucomatous visual field progression with frequency doubling technology and standard automated perimetry in a longitudinal prospective study. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):547-54.
Rai A, Varma DK, Ahmed IK. Suture fixation of iris-claw IOL. Journal of Cataract and Refractive Surgery. Journal of Cataract and Refractive Surgery. 2012 Mar;38(5):743.
Habeeb, Syed Y, Varma DK, and Ahmed IK. Oblique illumination and trypan blue to enhance visualization through corneal scars. Can J Ophthalmol. 2011 Dec;46(6):555-6.
Varma DK, Shaikh VM, Hillson TR, Ahmed IK. Migration of retained broken chopper tip after phacoemulsification. Journal of Cataract and Refractive Surgery. 2010 May;36(5):657-6.0
Varma DK, Brownstein S, Hodge WG, Faraji H. Generalized Posterior Keratoconus: Clinical Pathological Correlations. Can J Ophthalmol. 2008 Aug;43(4):480-2.
Dr. Iqbal “Ike” Ahmed, MD, FRCSC, Ophthalmologist
Glaucoma & Anterior Segment Surgeon
Chief of Innovation, Prism Eye Institute
About Dr. Ahmed
Dr. Ike K. Ahmed is a fellowship-trained glaucoma, cataract, and anterior segment surgeon with a research and practice focus on the management of glaucoma, complex cataract and intraocular lens complications. He practices and is board certified in ophthalmology in Canada and the USA and is an active member of numerous national and international societies.
Dr. Ahmed is recognized as being one of the most experienced complex eye surgeons in the world and has become renowned for his skills and groundbreaking work in the surgical treatment of highly complex eye diseases including glaucoma and surgical complications. He is known to be a disruptive thinker and values the power of the human spirit, passion, collaboration, and energy to challenge the status quo.
He has done pioneering work in innovative glaucoma therapeutics, developing and coining the term “Micro-Invasive Glaucoma Surgery (MIGS)” and “Interventional Glaucoma” as a new genre of surgical approaches and devices. Dr. Ahmed has become one of the most recognized eye surgeons in the world and was recently recognized as the “2nd most influential ophthalmologist” in the world by the news magazine The Ophthalmologist.
Patients are referred to him locally, nationally, and from around the world. He has been invited to perform surgery in four continents across the globe. Dr. Ahmed was selected as one of Canada’s “Top 40 Under 40”—a prestigious national award recognizing significant achievements at a young age. He was selected to receive the prestigious Binkhorst medal at ASCRS, which is awarded to the world’s most prominent ophthalmologists whose careers have made significant contributions to the science and practice of ophthalmology.
The American Glaucoma Society honoured him with the AGS Surgery Day Lecture, and the UKISCRS bestowed him with the Pearce Medal Lecture in 2015. In 2017, he was awarded “Innovator of the Year” by the Eye Physicians and Surgeons of Ontario.
Dr. Ahmed has a large tertiary glaucoma/complex cataract practice at Prism Eye Institute (www.prismeyeinstitute.com) in the Greater Toronto Area, and primarily performs surgery at Trillium Health Partners, Mississauga, Ontario, the Kensington Eye Institute, University of Toronto, Toronto, Ontario, and TLC Oakville.
In 2021, Dr. Ahmed took on a new initiative as Director of the new Alan S. Crandall Center for Glaucoma Innovation (www.crandallcenter.com) at the John A. Moran Eye Center and became a tenured Professor at the University of Utah, Department of Ophthalmology and Visual Sciences. This is a part-time position that compliments his work in Toronto. Embedded within the incredible resources, clinicians, and scientists at the Moran, the center is poised to tackle the global burden of eye disease by developing better diagnostic tools, designing safer and more effective treatments, and teaching and training. He also sees patients and operates at the John A. Moran Eye Center in Salt Lake City, Utah.
Dr. Ahmed has a keen interest in the development of advanced microsurgical devices and techniques in glaucoma and complicated cataract extraction and is actively involved in research and medical education at a national and international level. He has received research grants to study glaucoma diagnostics and therapies, anterior segment and retinal/optic nerve imaging, cataract surgical techniques and devices, and intraocular lens designs.
Dr. Ahmed has designed innovative diamond scalpels for surgery, microsurgical instrumentation, and devices, implants, and techniques for the management of the dislocated cataract, iris reconstruction, and glaucoma implant devices. He also performed the first laser cataract surgery in Canada.
As a result of his innovative expertise, Dr. Ahmed has been asked to consult for many companies and manufacturers, especially pertaining to the development of new devices and technologies. He sits on numerous scientific advisory boards and is a consultant to over 50 medical companies. He has served as medical monitor and as a principal investigator for some of the largest clinical trials in Ophthalmology.
He founded and currently directs The Toronto Cataract Course, The IOL Course for Canadian Residents, and the COS Surgical Teaching Series, as well as a number of AAO and ASCRS Courses. He sits on the editorial boards of pre-eminent journals in the field, including Ophthalmology, Ophthalmology-Glaucoma, Journal of Glaucoma, and Canadian Journal of Ophthalmology. He also holds editorial positions on EyeNet, Ocular Surgery News, Cataract and Refractive Surgery Today, In 2018 he was appointed as the Chief Medical Editor of Glaucoma Today.
Dr. Ahmed has been Principal Investigator for numerous research studies and has served as medical monitor for many pivotal clinical trials. He has published over 200 peer-reviewed papers and has published books on Glaucoma Surgery, Intraocular Lens Surgery, and Advanced Anterior Segment Surgery. He has won five film festival awards, ten best papers of session, and a poster award at ASCRS, as well as an ESCRS first place video award and AAO “Best of Show” award. He has given over 1000 scientific presentations thus far in his career, including forty visiting professor’s lectures around the world.
He is the Director of the Glaucoma and Advanced Anterior Segment Surgery (GAASS) fellowship at the University of Toronto, and Director of Research at the Kensington Eye Institute, University of Toronto. He has trained glaucoma specialists and cataract/anterior segment surgeons who are now practicing around the world.
As a result of his innovative expertise, Dr. Ahmed has been asked to consult for a variety of companies and manufacturers, especially pertaining to the development of new devices and technologies. In addition to his passion for technology, he loves travelling, running, and spending time with family.
Education
Glaucoma & Anterior Segment Surgery Fellowship, John Moran Eye Center, University of Utah
Ophthalmology Residency, University of Toronto Hospitals
Medical & Surgical Internship, University of Toronto Hospitals
Doctor of Medicine, University of Toronto
Awards & Accomplishments
2023 Stephen A. Obstaum Honored Lecture
American Society of Cataract and Refractive Surgeons
2023 Ophthalmologist Power List
#5 Top 100 Most Influential People in the World of Ophthalmology
2022 Ophthalmologist Power List
#2 Top 100 Most Influential People in the World of Ophthalmology
2021 Walk of Fame
Sorocaba Eye Bank International Symposium
2021 Kelman Award
Hellenic Society of Intraocular Implant and Refractive Surgery
2021 LIM Lecture Award
Asia-Pacific Association of Cataract & Refractive Surgeons
2018 Clinical Innovator Award
Ophthalmology Innovation Summit
2017 Innovator Award
Eye Physicians and Surgeons of Ontario
2015 Glaucoma Day Surgery Lecture Award
American Glaucoma Society
2015 Pearce Medal Lecture Award
UK & Ireland Society of Cataract & Refractive Surgeons
2014 Binkhorst Medal
American Society of Cataract and Refractive Surgeons
Awarded for outstanding contributions to the understanding and practice of cataract surgery and IOL implantation.
2014 Innovator Award
Connecticut Society of Eye Physicians
2013 AAO Senior Achievement Award
American Academy of Ophthalmology
Awarded for substantial contributions to the scientific programs at the Annual Meeting
2013 ACOS Visionary Award
American-European Congress of Ophthalmic Surgery
2012 Annual Glaucoma Research Award for Best Published Paper of
Canadian Glaucoma Society
Awarded for the best glaucoma paper published from a Canadian researcher for “The Ahmed versus Baerveldt Study: One-Year Treatment Outcomes”
2012 ASCRS “Best Paper of Session” Award
Symposium on Cataract, IOL and Refractive Surgery
Award in Glaucoma for “Intracanalicular Scaffold for IOP Reduction After Cataract Surgery in Mild to Moderate Open-Angle Glaucoma.”
2012 ASCRS Glaucoma Day “Reay of Hope” Award
Symposium on Cataract, IOL and Refractive Surgery
2011 AAO Best Poster Award
American Academy of Ophthalmology
Award for “OCT Imaging of Suprachoroid after Cypass Implantation”
2011 Silver Needle Award
University of Toronto Ophthalmology Residency Program
Award by graduating resident for best surgical teacher
2010 Best Glaucoma Paper
Canadian Ophthalmological Society
Awarded for “The Ahmed versus Baerveldt Study: Two-Year Follow-Up Results”
2010 “Top 40 under 40” in Canada
Awarded for outstanding contribution and leadership at a young age in Canada.
2010 Premier Surgeon 250
The PS250 is a list of 250 surgeons the publisher and editors of Premier Surgeon have identified as leading innovators in the field of premium IOL surgery.
2006 Top 50 Cataract and Refractive Opinion Leaders
Cataract and Refractive Surgery Today (CRST)
Awarded for outstanding contribution and leadership in the fields of Cataract and Refractive Surgery as voted on by readers of CRST.
Academic & Hospital Appointments
Professor of Ophthalmology and Visual Sciences, John. A Morgan Eye Center, University of Utah
Assistant Professor, Department of Ophthalmology, University of Toronto
Director, Alan S. Crandall Center for Glaucoma Innovation, John A. Moran Eye Center
Director, Glaucoma & Anterior Segment Surgery (GAASS) Fellowship, University of Toronto
Research Director, Kensington Eye Institute, University of Toronto
Division Head, Ophthalmology, Trillium Health Partners, Mississauga, ON
Chief of Innovation, Prism Eye Institute
Memberships
Royal College of Physicians and Surgeons of Canada
American Board of Ophthalmology
Research
Armstrong JJ, De Francesco T, Ma J, Schlenker MB, Ahmed IIK. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: 3-year results as a primary surgical intervention Ophthalmol Glaucoma. 2023 Apr 10:S2589-4196(23)00067-4. doi: 10.1016/j.ogla.2023.04.002. Online ahead of print.
Gedde SJ, Lim KS, Barton K, Goyal S, Ahmed II, Brandt JD. Reply Ophthalmology. 2023 Apr 6:S0161-6420(23)00153-7. doi: 10.1016/j.ophtha.2023.03.001. Online ahead of print.
Ahmed IIK, Sheybani A, De Francesco T, Lass JH, Benetz BA, Samuelson TW, Usner D, Katz LJ. Long-Term Endothelial Safety Profile With iStent Inject in Patients With Open-Angle Glaucoma Am J Ophthalmol. 2023 Mar 1;252:17-25. doi: 10.1016/j.ajo.2023.02.014. Online ahead of print.
Ahmed IIK, Sadruddin O, Panarelli JF. Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma Eye Vis (Lond). 2023 Mar 2;10(1):10. doi: 10.1186/s40662-022-00322-1.
Montesano G, Ometto G, Ahmed IIK, Ramulu PY, Chang DF, Crabb DP, Gazzard G. Five-Year Visual Field Outcomes of the HORIZON Trial Am J Ophthalmol. 2023 Feb 21;251:143-155. doi: 10.1016/j.ajo.2023.02.008. Online ahead of print.
Waldner DM, Chaban Y, Penny MD, Al-Ani A, Belkin A, Ahmed IIK, Schlenker MB, Gooi P. Segmental Suture Gonioscopy-Assisted Transluminal Trabeculotomy: Comparison of Superior Versus Inferior Hemisphere Outcomes J Glaucoma. 2023 May 1;32(5):396-406. doi: 10.1097/IJG.0000000000002169. Epub 2022 Dec 28.
Balas M, Kwok JM, Miguel A, Rai A, Rai A, Ahmed IIK, Schlenker MB. The Cataract Surgery Learning Curve: Quantitatively Tracking a Single Resident’s Operative Actions Throughout Their Training Am J Ophthalmol. 2023 May;249:82-89. doi: 10.1016/j.ajo.2022.12.006. Epub 2022 Dec 26.
Schlenker MB, Sayal AP, Yang M, Reid R, Ahmed IIK. Visual acuity, patient-reported outcome measures, or both? The development of an evidence-based appropriateness and prioritization tool for cataract surgery patients Can J Ophthalmol. 2023 Apr;58(2):e74-e76. doi: 10.1016/j.jcjo.2022.07.010. Epub 2022 Aug 24.
Yonamine S, Ton L, Rose-Nussbaumer J, Ying GS, Ahmed IIK, Chen TC, Weiner A, Gedde SJ, Han Y. Survey of the American Glaucoma Society Membership on Current Glaucoma Drainage Device Placement and Postoperative Corticosteroid Use Clin Ophthalmol. 2022 Jul 21;16:2305-2310. doi: 10.2147/OPTH.S369673. eCollection 2022.
Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed II, Brandt JD; Primary Tube Versus Trabeculectomy Study Group. Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up Ophthalmology. 2022 Dec;129(12):1344-1356. doi: 10.1016/j.ophtha.2022.07.003. Epub 2022 Jul 12.
Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed II, Brandt JD; Primary Tube Versus Trabeculectomy Study Group. Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up Ophthalmology. 2022 Dec;129(12):1357-1367. doi: 10.1016/j.ophtha.2022.07.004. Epub 2022 Jul 12.
Ma J, Issa M, Varma D, Ahmed IIK. Urgent Virtual Eye Assessments During the COVID-19 Pandemic Clin Ophthalmol. 2022 Jun 23;16:2069-2078. doi: 10.2147/OPTH.S353660. eCollection 2022.
Medeiros FA, Sheybani A, Shah MM, Rivas M, Bai Z, Werts E, Ahmed IIK, Craven ER. Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension Ophthalmol Ther. 2022 Aug;11(4):1517-1537. doi: 10.1007/s40123-022-00527-6. Epub 2022 May 28.
Marolo P, Reibaldi M, Fallico M, Maugeri A, Barchitta M, Agodi A, Parisi G, Caselgrandi P, Ventre L, Ahmed IIK. Reintervention rate in glaucoma filtering surgery: A systematic review and meta-analysis Eur J Ophthalmol. 2022 Sep;32(5):2515-2531. doi: 10.1177/11206721221093828. Epub 2022 Apr 27.
Kryshtalskyj MT, Rai AS, Durr GM, Ahmed IIK. Development and validation of the Iris Glare, Appearance, and Photophobia questionnaire for patients with iris defects J Cataract Refract Surg. 2022 Oct 1;48(10):1141-1147. doi: 10.1097/j.jcrs.0000000000000939.
Mikula ER, Raksi F, Ahmed IIK, Sharma M, Holland G, Khazaeinezhad R, Bradford S, Jester JV, Juhasz T. Femtosecond Laser Trabeculotomy in Perfused Human Cadaver Anterior Segments: A Novel, Noninvasive Approach to Glaucoma Treatment Transl Vis Sci Technol. 2022 Mar 2;11(3):28. doi: 10.1167/tvst.11.3.28.
Bowden EC, Choudhury A, Gedde SJ, Feuer WJ, Christakis PG, Savatovsky E, Han Y, Ahmed IIK, Budenz DL; ABC, AVB, and TVT Study Groups. Risk Factors for Failure of Tube Shunt Surgery: A Pooled Data Analysis Am J Ophthalmol. 2022 Aug;240:217-224. doi: 10.1016/j.ajo.2022.02.027. Epub 2022 Mar 12.
Ahmed IIK, De Francesco T, Rhee D, McCabe C, Flowers B, Gazzard G, Samuelson TW, Singh K; HORIZON Investigators. Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery Ophthalmology. 2022 Jul;129(7):742-751. doi: 10.1016/j.ophtha.2022.02.021. Epub 2022 Feb 23.
Belkin A, Chaban YV, Waldner D, Samet S, Ahmed IIK, Gooi P, Schlenker MB. Gonioscopy-assisted transluminal trabeculotomy is an effective surgical treatment for uveitic glaucoma Br J Ophthalmol. 2023 May;107(5):690-697. doi: 10.1136/bjophthalmol-2021-320270. Epub 2021 Dec 20.
Moreno-Valladares A, Puerto Amorós N, Mendez Llatas M, Pazos-López M, Ahmed IIK. Combined excimer laser trabeculostomy and phacoemulsification: One year follow-up real world data of a laser-based MIGS Arch Soc Esp Oftalmol (Engl Ed). 2021 Dec;96(12):631-639. doi: 10.1016/j.oftale.2020.12.004. Epub 2021 May 20.
Kao BW, Meer E, Barbolt TA, Lewis RA, Ahmed IIK, Lee V, Nicaise SM, Griggs G, Miller-Ellis EG. Biocompatibility and feasibility of VisiPlate, a novel ultrathin, multichannel glaucoma drainage device J Mater Sci Mater Med. 2021 Nov 24;32(12):141. doi: 10.1007/s10856-021-06613-8.
Ahmed Y, Pereira A, Bowden S, Shi RB, Li Y, Ahmed IIK, Arshinoff SA. Multicenter Comparison of the Toronto Portable Perimeter with the Humphrey Field Analyzer: A Pilot Study Ophthalmol Glaucoma. 2022 Mar-Apr;5(2):146-159. doi: 10.1016/j.ogla.2021.07.011. Epub 2021 Aug 4.
Schlenker MB, Samet S, Lim M, D’Silva C, Reid RJ, Ahmed IIK. Physician and patient concordance in reporting of appropriateness and prioritization for cataract surgery PLoS One. 2021 Jun 25;16(6):e0253210. doi: 10.1371/journal.pone.0253210. eCollection 2021.
De Francesco T, Ma J, Ahmed IIK. Endothermal pupilloplasty to optimize pupil centration, size, and contour J Cataract Refract Surg. 2021 Dec 1;47(12):e80-e83. doi: 10.1097/j.jcrs.
Saheb H, Donnenfeld ED, Solomon KD, et al. Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma.Curr Eye Res 2021;46:224-231.
Nichani P, Popovic MM, Schlenker MB, Park J, Ahmed IIK. Microinvasive glaucoma surgery: A review of 3476 eyes. Surv Ophthalmol 2021;66:714-742.
Mustafa M, Shoham-Hazon N, Reiss GR, Samuelson TW, Condon G, Ahmed IIK. Neodymium Laser Treatment of IOP Rise Following Ex-Press Glaucoma Device Implantation: A Retrospective Review From 4 Institutions. J Glaucoma 2020;29:92-96.
Moreno-Valladares A, Puerto Amorós N, Mendez Llatas M, Pazos-López M, Ahmed IIK. Combined excimer laser trabeculostomy and phacoemulsification: One year follow-up real world data of a laser-based MIGS. Archivos de la Sociedad Espanola de Oftalmologia 2021;96:631-639.
Mansour AM, Ahmed IIK, Charbaji AR, Mansour HA, El Jawhari KM. Associations in corticocapsular adhesions. Eye (London, England) 2021.
Lamba A, Pereira A, Varma D, Shahidi A, Smith D, Ahmed IIK. Retrospective analysis on the visual outcomes and photic phenomena following bilateral extended depth of focus intraocular lens implants. Can J Ophthalmol 2020;55:126-130.